| Definition for idiopathic gastric acid hypersecretion. A statistical and functional evaluation. | |
| | |
MedLine Citation:
|
PMID: 1914757 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Zollinger-Ellison syndrome and other gastric acid hypersecretory states in which a specific etiology is identified are defined as a basal acid output of greater than 15.0 meq/hr. To determine the level of basal acid output that defines idiopathic gastric hypersecretion, basal acid outputs were investigated in normal subjects and patients with duodenal ulcers, and functional and statistical definitions for idiopathic gastric acid hypersecretion were developed. Sixty-five normal subjects were evaluated to define idiopathic gastric acid hypersecretion on a statistical basis, and 22 patients with refractory duodenal ulcers were evaluated to define idiopathic gastric acid hypersecretion on a functional basis. Mean basal acid output for the 65 normal subjects was 3.0 +/- 2.7 meq/hr. Even though the mean basal acid output for the group of 28 normal male subjects was slightly higher than for the group of 37 normal female subjects, the groups were not significantly different. The 95% confidence interval around the mean basal acid output for all normal subjects was 2.4-3.7 meq/hr, with little difference between the male and female groups. The mean basal acid output plus two standard deviations and the mean basal acid output plus three standard deviations for the 65 normal subjects were 8.4 meq/hr and 11.1 meq/hr, respectively. Of 109 patients with active duodenal ulcers treated for eight weeks with standard doses of antisecretory medication, 22 showed no healing as documented by endoscopy.(ABSTRACT TRUNCATED AT 250 WORDS) |
| | |
Authors:
|
M J Collen; M J Sheridan |
Related Documents
:
|
8545617 - Eradication of helicobacter pylori infection in patients with non-ulcer dyspepsia. effe... 1032067 - Gastric acid secretion in patients with prepyloric ulcer and with combined gastric and ... 2806387 - Primary irritant reactions in the skin of the pika, ochotona rufescens rufescens. 947637 - Phosphatidylcholine content and fatty acid composition of tracheal and gastric liquids ... 2151387 - Biochemical efa status of mothers and their neonates after normal pregnancy. 8545617 - Eradication of helicobacter pylori infection in patients with non-ulcer dyspepsia. effe... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Digestive diseases and sciences Volume: 36 ISSN: 0163-2116 ISO Abbreviation: Dig. Dis. Sci. Publication Date: 1991 Oct |
Date Detail:
|
Created Date: 1991-11-05 Completed Date: 1991-11-05 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 7902782 Medline TA: Dig Dis Sci Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 1371-6 Citation Subset: AIM; IM |
Affiliation:
|
Department of Medicine, Loma Linda University Medical Center, California. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Cimetidine / therapeutic use Duodenal Ulcer / drug therapy, metabolism*, physiopathology Famotidine / therapeutic use Female Gastric Acid / secretion* Humans Male Middle Aged Ranitidine / therapeutic use Reference Values |
| Chemical | |
Reg. No./Substance:
|
51481-61-9/Cimetidine; 66357-35-5/Ranitidine; 76824-35-6/Famotidine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after...
Next Document: Very-low dose antacid in treatment of duodenal ulcer. Comparison with cimetidine.